Definition And Epidemiology
- Acute inflammatory upper airway obstruction.
- Characterized by bark-like or metallic/brassy cough, hoarseness, inspiratory stridor, and respiratory distress.
- Highest incidence among preschool children, peaking between 6 months to 3 years of age.
- Peak incidence in the second year of life.
- Predominantly affects males.
- Seasonal variation observed with higher occurrence during autumn and winter months.
- Hospitalization required in <5% of cases; intensive care needed in 1-2% of hospitalized cases.
- Mortality rate extremely low (<0.5%).
Etiology
- Viral infection of the glottic and subglottic regions.
- Parainfluenza virus types 1 and 3 account for >70% of cases.
- Other viral agents: Parainfluenza type 2, Influenza A and B, Adenovirus, Respiratory Syncytial Virus (RSV), Metapneumovirus, Coronavirus, and Measles.
- Mycoplasma pneumoniae rarely isolated, causes mild disease.
Pathophysiology
- Viral infection spreads to larynx and trachea.
- Inflammation leads to edema, abnormal secretions, and cellular debris.
- Decreased laryngeal and subglottic airway diameter causes obstruction.
- Small caliber of pediatric airways dramatically increases airway resistance with minimal mucosal edema.
- Inspiratory stridor results from turbulent airflow through narrowed extrathoracic airway.
- Alveolar gas exchange remains normal; hypoxia occurs only with impending complete airway obstruction.
Clinical Manifestations
- Upper respiratory infection (URI) prodrome: Rhinorrhea, pharyngitis, mild cough, low-grade fever lasting 1-3 days.
- Sudden onset of distinctive barking cough, hoarseness, and inspiratory stridor.
- Symptoms worsen at night.
- Agitation and crying significantly aggravate symptoms and signs.
- Physical examination reveals normal to moderately inflamed pharynx, tachypnea, nasal flaring, and chest retractions.
- Preference to sit upright in bed.
Croup Variants
- Spasmodic Croup:
- Occurs in children aged 1-3 years.
- Sudden onset in early morning hours.
- Absence of viral prodrome, coryza, or fever.
- Resolves rapidly within a few hours.
- High recurrence rate; possible allergic component or associated with gastroesophageal reflux disease (GERD).
Clinical Severity Assessment
Clinical severity guides management. Assessed using sensorium, distress, stridor, heart rate, and oxygen saturation.
Stridor Severity
| Sign |
Mild |
Moderate |
Severe |
Life-Threatening |
| Sensorium |
Alert |
Irritable but comforted |
Restless, agitated |
Lethargic, pain responsive, or unresponsive |
| Stridor |
Audible on coughing, none at rest |
Stridor at rest, worse on agitation |
Severe stridor at rest, worsens on agitation |
Audible stridor becoming quiet without improved consciousness |
| Respiratory Distress |
None |
Tachypnea, suprasternal/subcostal retractions |
Marked tachypnea, severe retractions |
Declining intensity of retractions without clinical improvement |
| Heart Rate |
Normal |
Tachycardia |
Tachycardia |
Bradycardia |
| SpO2 (Room Air) |
>95% |
>92-95% |
<92% |
<90%, cyanosis |
Weasley Croup Score
| Clinical Feature |
0 Points |
1 Point |
2 Points |
3 Points |
| Cyanosis |
None |
|
With agitation/activity |
At rest |
| Level of Consciousness |
Normal |
|
|
Disoriented / Depressed |
| Stridor |
None |
Only with agitation/activity |
At rest |
|
| Air Entry |
Normal |
Decreased |
Markedly decreased |
|
| Retractions |
None |
Mild |
Moderate |
Severe |
| Total Score |
Severity |
Management Guidance |
| 0 - 2 |
Mild |
Usually manageable at home; single dose of oral dexamethasone. |
| 3 - 7 |
Moderate |
Requires medical evaluation; oral/IM dexamethasone, consider nebulized epinephrine and observation. |
| 8 - 11 |
Severe |
Urgent intervention; nebulized epinephrine, systemic corticosteroids, likely hospitalization/ICU monitoring. |
| ≥ 12 |
Impending Respiratory Failure |
Emergency critical care; aggressive airway support, continuous nebulization, intensive care admission. |
Differential Diagnosis
Must differentiate from other causes of acute upper airway obstruction.
| Feature |
Viral Croup |
Acute Epiglottitis |
Bacterial Tracheitis |
Retropharyngeal Abscess |
Foreign Body Aspiration |
| Age |
6 months - 3 years |
3 - 14 years |
6 months - 14 years |
2 - 4 years |
6 months - 3 years |
| Onset |
Gradual (Days) |
Very Rapid (Hours) |
Rapid |
Gradual |
Sudden (Minutes) |
| Appearance |
Nontoxic |
Toxic |
Toxic |
Toxic |
Nontoxic |
| Fever |
Low-grade |
High-grade |
High-grade |
High-grade |
Afebrile |
| Cough |
Barking |
Absent |
Barking, productive |
Absent |
Choking, gagging |
| Drooling |
Absent |
Present |
Absent |
Present |
Absent |
| Dysphagia |
Absent |
Severe |
Absent |
Present |
Absent |
| Voice |
Hoarse |
Muffled |
Very hoarse |
Muffled |
Normal or aphonic |
| Posture |
No preference |
Tripod/sniffing |
No preference |
Neck extension |
No preference |
Investigations
- Diagnosis is primarily clinical.
- Avoid distressing interventions (phlebotomy, IV access, throat examination) to prevent sudden airway obstruction.
- Radiology:
- Anteroposterior (AP) Neck X-ray: "Steeple sign" (subglottic narrowing).
- Lateral Neck X-ray: Helps rule out Epiglottitis ("thumb sign") or retropharyngeal abscess.
- Caution: Never shift an unstable child for X-rays before stabilization. Radiographic findings are neither completely sensitive nor specific.
- Laboratory:
- Complete Blood Count (CBC): Neutrophilic leukocytosis (nonspecific).
- C-Reactive Protein (CRP): Elevation suggests bacterial etiology (Tracheitis/Epiglottitis).
Management
Initial Stabilization
- Keep infant on mother’s lap; separation worsens stridor.
- Administer oxygen in a nonthreatening manner to maintain SpO2 >95%.
- Withhold throat examination with tongue depressor until airway secured.
- Avoid sedation.
Mild Croup
- Corticosteroids:
- Single dose oral Dexamethasone (0.6 mg/kg) OR nebulized Budesonide (2 mg).
- Discharge home if stable.
- Counsel parents on natural course (resolution in 48-72 hours) and warning signs (poor feeding, altered sensorium, worsening stridor).
- No role for antibiotics or beta-agonist bronchodilators.
Moderate to Severe Croup
- Hospitalization preferred.
- Nebulized Adrenaline (L-epinephrine):
- Dose: 0.5 mL/kg of undiluted 1:1000 adrenaline (maximum 5 mL).
- Mechanism: Constricts precapillary arterioles via beta-adrenergic receptors, decreasing laryngeal mucosal edema.
- Duration of action: <2 hours. Requires minimum 2-4 hours observation for rebound symptoms.
- Repeat dose after 2 hours if necessary.
- Corticosteroids:
- Mandatory even if responsive to adrenaline (adrenaline effect wanes).
- Dexamethasone 0.6 mg/kg (maximum 8 mg) via Oral, IV, or IM route.
- Nebulized Budesonide 2 mg.
- Provide supplemental oxygen for SpO2 <95%.
Indications for Intubation / Intensive Care
- Depressed sensorium (lethargy, unresponsive).
- Severe retractions with declining intensity (muscle fatigue).
- Cyanosis or SpO2 <90% despite oxygen therapy.
- Procedure: Secure airway in a controlled setting. Use an endotracheal tube 0.5 - 1.0 mm smaller than estimated for age/height.
Discharge Criteria
- Observation for at least 2-3 hours post-adrenaline nebulization.
- No stridor at rest.
- Normal air entry.
- Normal pulse oximetry.
- Normal level of consciousness.
- Received systemic corticosteroids.
Complications And Prognosis
- Complications: Occur in ~15% of cases.
- Extension of infection: Otitis media, terminal bronchiolitis, pneumonia.
- Bacterial superinfection: Bacterial tracheitis.
- Rare: Toxic shock syndrome (if associated with S. aureus or S. pyogenes tracheitis).
- Prognosis:
- Excellent overall prognosis.
- Majority of deaths result from laryngeal obstruction prior to medical intervention or tracheotomy complications.